Ispire Technology Inc. Common Stock

Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value

Ispire Technology Inc. to Participate in the 38th Annual ROTH Conference

Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026

Ispire-Backed IKE Tech Invited to Participate in FDA Roundtable on PMTA Submissions

Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call